Company intelligence / Profile preview

WeSee Imaging

Wuhan, Hubei Province, Chinam.wesee-imaging.com ↗

Ownership: Private
Development stage: Preclinical

Overview

WeSee Imaging has developed and commercialized a breast ultrasound computed tomography system designed to improve the accuracy and safety of breast cancer screening. The company’s technology offers full-chain solutions in medical imaging with a focus on non-invasive, radiation-free diagnostics for early detection of breast diseases.

Therapeutic areas: Oncology
Modalities: DeviceUltrasound CT imaging system
Industry: Medical Imaging

Beyond the preview

Go deeper on WeSee Imaging.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on WeSee Imaging.

Explore the full profile